Chester County News and Community Website
MyChesCo is your one-stop-shop for reliable news and updated analysis on Business in Montgomery County, Pennsylvania. Our team of journalists is committed to providing accurate and up-to-date coverage of the latest news and headlines affecting the Montgomery County business community. Keep up to date with the latest developments and stay informed with MyChesCo.
At MyChesCo, we provide comprehensive coverage and analysis of the latest Montgomery County business news and headlines affecting Montgomery County. Our experienced team of reporters brings you in-depth insights and updates on the latest developments in Montgomery County, as well as the rest of Pennsylvania. Get the top headlines and reliable coverage on Montgomery County business news with MyChesCo.
Stay informed with MyChesCo, the leading source for reliable news and updated analysis on Business in Montgomery County, Pennsylvania. Our team is committed to providing timely and accurate coverage of the latest news and headlines, so you can stay up to date with the developments in the Montgomery County business community. Get the coverage you need to stay informed with MyChesCo.
BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) has announced an updated timeline for submitting its Biologics License Application (BLA) for nomlabofusp, a potential first-in-class treatment for Friedreich’s Ataxia …
Larimar Therapeutics Aligns with FDA Guidance, Revises Nomlabofusp Submission Timeline Read More BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) announced a conference call and webcast to discuss regulatory updates for the nomlabofusp clinical development program for Friedreich’s Ataxia on Monday, …
Larimar Therapeutics to Host Conference Call on Friedreich’s Ataxia Updates Read More
CONSHOHOCKEN, PA — The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Madrigal Pharmaceuticals’ (NASDAQ: …
Madrigal Pharmaceuticals Receives Positive CHMP Opinion for Resmetirom in Treating MASH Read More
KING OF PRUSSIA, PA — JM Search has released its 2025 CFO Compensation & Insights Study. This comprehensive report provides critical benchmarking data on CFO compensation and sheds light on …
JM Search Unveils 2025 CFO Compensation & Insights Study Read More
FORT WASHINGTON, PA — Toll Brothers, Inc. (NYSE: TOL) announced that its Board of Directors has approved a quarterly cash dividend of $0.25 per share, payable on July 25, 2025, …
Toll Brothers Declares $0.25 Quarterly Dividend for July 2025 Read More
BLUE BELL, PA — inTRAvent Medical has announced the appointment of Dr. Adam S. Arthur, MD, MPH, as Chief Clinical Strategy Officer (CCSO). Dr. Arthur will play a pivotal role …
inTRAvent Medical Appoints Dr. Adam S. Arthur as Chief Clinical Strategy Officer Read More
LANSDALE, PA — Marvin’s Home, a non-profit organization focused on supporting individuals aging out of the foster care system, has achieved a significant milestone, completing its 100th apartment makeover and …
Marvin’s Home Completes 100th Apartment Makeover, Celebrates Milestone Read More
KING OF PRUSSIA, PA — The Goddard School® has announced the recipients of its 2025 Circle of Excellence and President’s Club awards, celebrating top-performing schools for their exceptional achievements in …
The Goddard School Recognizes Top Achievers with 2025 Circle of Excellence and President’s Club Awards Read More CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) announced it granted equity awards on June 15, 2025, to 36 new non-executive employees under Madrigal’s 2023 Inducement Plan. The awards were …
Madrigal Pharmaceuticals Awards Equity Grants to New Employees Under 2023 Inducement Plan Read More
KING OF PRUSSIA, PA — The U.S. Food and Drug Administration (FDA) has approved ANDEMBRY® (garadacimab-gxii), developed by CSL, as the first treatment targeting factor XIIa for the prevention of …
FDA Approves ANDEMBRY® for Preventing Hereditary Angioedema Attacks Read More